Oral solid formulation containing irinotecan and method of preparing the same

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11090299
APP PUB NO 20180153878A1
SERIAL NO

15735313

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

An oral solid formulation includes irinotecan or a pharmaceutically acceptable salt thereof as an active ingredient, and an acidifying agent.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
HANMI PHARM CO LTDHWASEONG-SI GYEONGGI-DO

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Jung, Myeong Ki Suwon-si, KR 2 1
Kim, Jin Cheul Seoul, KR 11 6
Kim, Yong Il Suwon-si, KR 149 1773
Park, Caleb Hyung Min Goyang-si, KR 2 1
Park, Jae Hyun Suwon-si, KR 322 1977
Woo, Jong Soo Suwon-si, KR 68 303

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Feb 17, 2025
7.5 Year Payment $3600.00 $1800.00 $900.00 Feb 17, 2029
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 17, 2033
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00